Infectious Diseases (except HIV/AIDS)

Heterologous SARS-CoV-2 IgA neutralising antibody responses in convalescent plasma

This article's authors
1. Samantha K Davis
2. Kevin John Selva
3. Ester Lopez
4. Ebene R Haycroft
5. Wen Shi Lee
6. Adam K Wheatley
7. Jennifer A Juno
8. Amy Adair
9. Phillip Pymm
10. Samuel J Redmond
11. Nicholas A Gherardin
12. Dale I Godfrey
13. Wai-Hong Tham
14. Stephen J Kent
15. Amy W Chung
This article has 1 evaluations Latest evaluation on Feb 11, 2022 Published on Feb 8, 2022
Evaluation of a Rapid and Accessible RT-qPCR Approach for SARS-CoV-2 Variant of Concern Identification

This article's authors
1. Priscilla S.-W. Yeung
2. Hannah Wang
3. Mamdouh Sibai
4. Daniel Solis
5. Fumiko Yamamoto
6. Naomi Iwai
7. Becky Jiang
8. Nathan Hammond
9. Bernadette Truong
10. Selamawit Bihon
11. Suzette Santos
12. Marilyn Mar
13. Claire Mai
14. Kenji O. Mfuh
15. Jacob A. Miller
16. ChunHong Huang
17. Malaya K. Sahoo
18. James L. Zehnder
19. Benjamin A. Pinsky
This article has 1 evaluations Latest evaluation on Feb 11, 2022 Published on Mar 21, 2022
Antibody and memory B-cell immunity in a heterogeneously SARS-CoV-2 infected and vaccinated population

This article's authors
1. Eva Bednarski
2. Perla M Del Rio Estrada
3. Justin DaSilva
4. Celia Boukadida
5. Fengwen Zhang
6. Yara A Luna-Villalobos
7. Ximena Rodríguez-Rangel
8. Elvira Pitén-Isidro
9. Edgar Luna-García
10. Dafne Díaz Rivera
11. Dulce M López-Sánchez
12. Daniela Tapia-Trejo
13. Maribel Soto-Nava
14. Myriam Astorga-Castañeda
15. José O Martínez-Moreno
16. Guadalupe S Urbina-Granados
17. José A Jiménez-Jacinto
18. Francisco J Serna Alvarado
19. Yerania E Enriquez-López
20. Oliva López-Arellano
21. Gustavo Reyes-Teran
22. Paul D. Bieniasz
23. Santiago Avila-Rios
24. Theodora Hatziioannou
This article has 1 evaluations Latest evaluation on Feb 11, 2022 Published on Feb 8, 2022
Clinical and Economic Impact of COVID-19 on Plantation Workers: Preliminary Results from the Guatemala Agricultural Workers and Respiratory Illness Impact (AGRI) Study

This article's authors
1. Daniel Olson
2. Diva M. Calvimontes
3. Molly M. Lamb
4. Gerber Guzman
5. Edgar Barrios
6. Andrea Chacon
7. Neudy Rojop
8. Kareen Arias
9. Melissa Gomez
10. Guillermo Antonio Bolanos
11. Jose Monzon
12. Anna N. Chard
13. Chelsea Iwamoto
14. Lindsey M. Duca
15. Nga Vuong
16. Melissa Fineman
17. Kelsey Lesteberg
18. David Beckham
19. Mario L. Santiago
20. Kendra Quicke
21. Gregory Ebel
22. Emily Zielinski Gutierrez
23. Eduardo Azziz-Baumgartner
24. Frederick G. Hayden
25. Hani Mansour
26. Kathryn Edwards
27. Lee S. Newman
28. Edwin J. Asturias
This article has 1 evaluations Latest evaluation on Feb 11, 2022 Published on Feb 8, 2022
Clinical outcomes in hospitalized vaccine-breakthrough COVID-19 cases compared with contemporary unvaccinated hospitalized adults

This article's authors
1. Marcelo Wolff
2. Margarita Gilabert
3. Rodrigo Hernández
This article has 1 evaluations Latest evaluation on Feb 11, 2022 Published on Feb 8, 2022
SARS-CoV-2 Seroprevalence in three Kenyan Health and Demographic Surveillance Sites, December 2020-May 2021

This article's authors
1. Anthony O. Etyang
2. Ifedayo Adetifa
3. Richard Omore
4. Thomas Misore
5. Abdhalah K. Ziraba
6. Maurine A. Ng’oda
7. Evelyn Gitau
8. John Gitonga
9. Daisy Mugo
10. Bernadette Kutima
11. Henry Karanja
12. Monica Toroitich
13. James Nyagwange
14. James Tuju
15. Perpetual Wanjiku
16. Rashid Aman
17. Patrick Amoth
18. Mercy Mwangangi
19. Kadondi Kasera
20. Wangari Ng’ang’a
21. Donald Akech
22. Antipa Sigilai
23. Boniface Karia
24. Angela Karani
25. Shirine Voller
26. Charles N. Agoti
27. Lynette I. Ochola-Oyier
28. Mark Otiende
29. Christian Bottomley
30. Amek Nyaguara
31. Sophie Uyoga
32. Katherine Gallagher
33. Eunice W. Kagucia
34. Dickens Onyango
35. Benjamin Tsofa
36. Joseph Mwangangi
37. Eric Maitha
38. Edwine Barasa
39. Philip Bejon
40. George M. Warimwe
41. J Anthony G Scott
42. Ambrose Agweyu
This article has 1 evaluations Latest evaluation on Feb 11, 2022 Published on Feb 9, 2022
Genetic immune response and antibody repertoire of heterologous ChAdOx1-BNT162b2 vaccination in a Korean cohort

This article's authors
1. Hye Kyung Lee
2. Jinyoung Go
3. Heungsup Sung
4. Seong Who Kim
5. Mary Walter
6. Ludwig Knabl
7. Priscilla Furth
8. Lothar Hennighausen
9. Jin Won Huh
This article has 1 evaluations Latest evaluation on Feb 10, 2022 Published on Feb 8, 2022
Safety and efficacy of two immunization schedules with an inactivated SARS-CoV-2 vaccine in adults. A randomized non-inferiority clinical trial

This article's authors
1. Katia Abarca
2. Carolina Iturriaga
3. Marcela Urzúa
4. Nicole Le Corre
5. Augusto Pineda
6. Carolina Fernández
7. Angélica Domínguez
8. Pablo A González
9. Susan M Bueno
10. Paulina Donato
11. Pilar Espinoza
12. Daniela Fuentes
13. Marcela González
14. Paula Guzmán
15. Paula Muñoz
16. Carlos M Pérez
17. Marcela Potin
18. Álvaro Rojas
19. José V González-Aramundiz
20. Nicolás MS Gálvez
21. Francisca Aguirre-Boza
22. Sofía Aljaro
23. Luis Federico Bátiz
24. Yessica Campisto
25. Marcela Cepeda
26. Aarón Cortes
27. Sofía López
28. María Loreto Pérez
29. Andrea Schilling
30. CoronaVac03CL Study Group
31. Alexis M Kalergis
This article has 1 evaluations Latest evaluation on Feb 10, 2022 Published on Mar 28, 2022
Time to reinfection and vaccine breakthrough SARS-CoV-2 infections: a retrospective cohort study

This article's authors
1. Sevda Molani
2. Andrew M. Baumgartner
3. Yeon Mi Hwang
4. Venkata R. Duvvuri
5. Jason D. Goldman
6. Jennifer J. Hadlock
This article has 1 evaluations Latest evaluation on Feb 10, 2022 Published on Feb 8, 2022
Effectiveness of Covid-19 Vaccines against the SARS-COV-2-Delta (B.1.617.2) in China-A Real World Study

This article's authors
1. Xinge Ma
2. Jianfeng Han
3. Hongxia Li
4. Chang Liu
This article has 1 evaluations Latest evaluation on Feb 10, 2022 Published on Feb 8, 2022

Previous Next